Dr. Eduardo González focuses on patent prosecution for clients in the pharmaceutical and biotech industries.
Dr. Eduardo González is a member of the firm’s Intellectual Property Group, where he focuses on biotechnology patent prosecution and supports the firm’s FDA regulatory practice group. He is also a postdoctoral scholar at the University of California, Davis, where he is testing novel therapeutics and specializing in technical writing.
Dr. González earned his Ph.D. in pharmacology and toxicology, with an emphasis in biotechnology, from the University of California, Davis. His research focused on the neurotoxicity of chemical threats and the development of neuroprotective medical countermeasures for treating survivors. As a doctoral student, Dr. González received a National Institutes of Health federal research grant. He obtained his B.S. in environmental science and management, with an emphasis in toxicology, from the University of California, Davis.
Dr. González is fluent in Spanish.Show More